CARBOGEN AMCIS published Ground-mounted Photovoltaic System Commissioned at Hunzenschwil Site.
Public source
Publisher name
Public post
Summer has flown by, and we hope you had a great one! ☀️ Now it’s time to get back to business and to catch up on the CARBOGEN AMCIS content you may have missed over the…
Company
CARBOGEN AMCIS
BRINGING YOUR SCIENCE TO LIFE
- Industry
- Pharmaceutical Manufacturing
- Location
- Bubendorf, CH
- Company size
- 501–1,000 employees
About CARBOGEN AMCIS
CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more about us: www.carbogen-amcis.com
See moreLatest activity
Latest activity from CARBOGEN AMCIS
8 signals
Presence & Recognition
CARBOGEN AMCIS will exhibit at ChemOutsourcing from September 15 to 16 in Boston, Massachusetts.
Research & Knowledge
CARBOGEN AMCIS published Preparative Chromatography of Highly Potent Compounds.
Research & Knowledge
CARBOGEN AMCIS published Managing HPAPI Programmes under Accelerated Timelines.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Medichem
Medichem published its latest Sustainability Report showcasing actions, initiatives, and progress made throughout the year.
Research & Knowledge
Zambon
Zambon published its new Value Report online, reflecting on the company's progress, innovation, and commitment to creating sustainable value for patients, communities, and future generations.
Research & Knowledge
MSD Greece
MSD Greece published its latest Impact Report for 2025, achieving 100% sourcing of purchased electricity from renewable energy sources and a 31% reduction in operational greenhouse gas emissions compared to 2019 levels.
Research & Knowledge
Solvias
Solvias published a case study detailing how a pharmaceutical company scaled up the manufacturing of a peptide therapeutic by optimizing its crystallization process to avoid undesired polymorphs.
Research & Knowledge
Pharmaron